CONCURRENT CHEMORADIATION WITH THREE WEEKLY VERSUS WEEKLY CISPLATIN IN LOCALLY ADVANCED NASOPHARYNGEAL CANCER PATIENTS
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Ji Yun | - |
dc.contributor.author | Sun, Jong-Mu | - |
dc.contributor.author | Kim, Sung-Bae | - |
dc.contributor.author | Park, Keon Uk | - |
dc.contributor.author | Kim, Hoon-Kyo | - |
dc.contributor.author | Hong, Dae Sik | - |
dc.contributor.author | Kim, Jun Suk | - |
dc.contributor.author | Park, Keunchil | - |
dc.contributor.author | Ahn, Yong Chan | - |
dc.contributor.author | Ahn, Myung-Ju | - |
dc.date.accessioned | 2021-09-05T04:41:08Z | - |
dc.date.available | 2021-09-05T04:41:08Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2014-10 | - |
dc.identifier.issn | 0923-7534 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/97270 | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | OXFORD UNIV PRESS | - |
dc.title | CONCURRENT CHEMORADIATION WITH THREE WEEKLY VERSUS WEEKLY CISPLATIN IN LOCALLY ADVANCED NASOPHARYNGEAL CANCER PATIENTS | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Jun Suk | - |
dc.identifier.wosid | 000347163700238 | - |
dc.identifier.bibliographicCitation | ANNALS OF ONCOLOGY, v.25 | - |
dc.relation.isPartOf | ANNALS OF ONCOLOGY | - |
dc.citation.title | ANNALS OF ONCOLOGY | - |
dc.citation.volume | 25 | - |
dc.type.rims | ART | - |
dc.type.docType | Meeting Abstract | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.